2D82 image
Deposition Date 2005-12-01
Release Date 2006-04-04
Last Version Date 2024-05-29
Entry Detail
PDB ID:
2D82
Keywords:
Title:
Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein (CBP) Association
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
1
Selection Criteria:
structures with the least restraint violations
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CREB-binding protein
Gene (Uniprot):CREBBP
Chain IDs:A
Chain Length:121
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Target structure-based discovery of small molecules that block human p53 and CREB binding protein association
Chem.Biol. 13 81 90 (2006)
PMID: 16426974 DOI: 10.1016/j.chembiol.2005.10.014

Abstact

Lysine acetylation of human tumor suppressor p53 in response to cellular stress signals is required for its function as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis. Here, we report small molecules that block lysine 382-acetylated p53 association with the bromodomain of the coactivator CBP, an interaction essential for p53-induced transcription of the cell cycle inhibitor p21 in response to DNA damage. These chemicals were discovered in target structure-guided nuclear magnetic resonance spectroscopy screening of a focused chemical library constructed based on the structural knowledge of CBP bromodomain/p53-AcK382 binding. Structural characterization shows that these chemicals inhibit CBP/p53 association by binding to the acetyl-lysine binding site of the bromodomain. Cell-based functional assays demonstrate that the lead chemicals can modulate p53 stability and function in response to DNA damage.

Legend

Protein

Chemical

Disease

Primary Citation of related structures